BioImpacts (Jan 2018)

Chemiluminescence based immunoassay for the detection of heroin and its metabolites

  • Smritee Singh,
  • Priya Mishra,
  • Ivneet Banga,
  • Avanish S Parmar,
  • Prem Prakash Tripathi,
  • Sonu Gandhi

DOI
https://doi.org/10.15171/bi.2018.07
Journal volume & issue
Vol. 8, no. 1
pp. 53 – 58

Abstract

Read online

Introduction: Continuous use of opiates causes drug-related illnesses, which poses an alarming situation to develop sensitive detection platform. In this study, a highly sensitive and reliable chemiluminescence immunoassay (CI) has been developed for the detection of heroin and its major metabolites in spiked urine samples. Methods: To develop robust immunoassay, monoacetyl morphine-bovine serum albumin (MAM-BSA) conjugate was synthesized and characterized thoroughly by physicochemical techniques. The anti-MAM antibodies were developed, labeled with horseradish peroxidase (HRP) and immunoassay was developed to detect the presence of target drug in spiked urine samples. Results: A competitive CI was developed, where heroin, MAM, morphine, and codeine concentration were ranged from 0-1000 ng/ mL in spiked urine samples and limit of detection were 80, 95, 90, 75 pg/ mL. Conclusion: The developed CI is highly sensitive, specific, point of care, cost-effective and can be used as a routine technique for quantitative analysis for screening of narcotic drugs.

Keywords